In vivo genotoxicity study of titanium dioxide nanoparticles using comet assay following intratracheal instillation in rats
Development of safety profile evaluating pharmacokinetics, pharmacodynamics and toxicity of a combination of pioglitazone and olmesartan medoxomil in Wistar albino rats
Subacute toxicity assessment of carotenoids extracted from citrus peel (Nanfengmiju, Citrus reticulata Blanco) in rats
Predicting blood:air partition coefficients using basic physicochemical properties
Chitosan induced hepato-nephrotoxicity in mice with special reference to gender effect in glycolytic enzymes activities
Assessment of the health risks related to the presence of drug residues in water for human consumption: Application to carbamazepine
Discriminatory power of standard toxicity assays used to evaluate ingredients added to cigarettes
Biomonitoring Equivalents for benzene
In vitro enrofloxacin binding in human fecal slurries
A consistent and transparent approach for calculation of Derived No-Effect Levels (DNELs) for petroleum substances
A refined approach to estimate exposure for use in calculating the Maximum Residue Limit of veterinary drugs
Assessing the non-cancer risk for RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine) using physiologically based pharmacokinetic (PBPK) modeling
A nonclinical safety and pharmacokinetic evaluation of N6022: A first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma
Risk assessment of chlorpyrifos on rice and cabbage in China
Naphthalene animal carcinogenicity and human relevancy: Overview of industries with naphthalene-containing streams
Design and chemical evaluation of reduced machine-yield cigarettes
Further investigations into the genotoxicity of 2,6-xylidine and one of its key metabolites
Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern
Safety evaluation of Mucor rouxii CFR-G15 biomass containing ω-6 fatty acids in rats
Development of a unit risk factor for nickel and inorganic nickel compounds based on an updated carcinogenic toxicity assessment
A review of current smoke constituent measurement activities and aspects of yield variability
CYP2F2-generated metabolites, not styrene oxide, are a key event mediating the mode of action of styrene-induced mouse lung tumors